SARS-CoV-2, Influenza A, Influenza B Detection and Differentiation

Date of reception of the dossier

29.10.2021

Notified Body number

2797

Internal PECP dossier #

In vitro diagnostic medical device

The device is a qualitative real-time PCR test for the simultaneously detection and differentiation of SARS-CoV-2,
Influenza A, and Influenza B in respiratory specimens (Nasopharyngeal swab/nasal swab)

Intended purpose

P1

what is detected and/or measured
please specify the analyte(s) or marker(s), e.g. SARS-CoV-2 spike protein, Kel1 (K)

P2

function of the device
e.g. diagnosis, aid to diagnosis, monitoring, determining the infectious load, tissue typing etc

Detection and differentiation of Influenza A, Influenza B, and SARS-CoV-2 in
respiratory specimens

P3

the specific disorder, condition or risk factor of
interest that it is intended to detect, define or
differentiate e.g. hepatitis C infection, exposure to SARS-CoV-2, risk of HIV transmission in blood transfusion etc.

Influenza A infection, Influenza B infection,
SARS CoV-2 infection

P4

whether it is automated or not

Yes, automated

P5

whether it is qualitative, semi-quantitative or
quantitative

Qualitative

P6

type of specimen(s)
e.g. whole blood, serum, saliva etc

Nasopharyngeal swab
Nasal Swab

P7

where applicable, the testing population
e.g. persons with specific health conditions,
persons with specific symptoms, children in a
certain age range

Individuals suspected of respiratory viral
infection consistent with COVID-19 by their healthcare provider

P8

intended user

Health professionals or trained operators
who are proficient in using the automated
platform, including in Near Patient Testing
environments

Technology

T1

principle of the assay method or principles of operation of the instrument e.g. real-time PCR, qualitative PCR, digital PCR, sandwich immunoassay, competitive immunoassay, immunoturbidimetric assay etc.

Real-time PCR

In this post ...